BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer

  June 2, 2025

   · 

  3 min read
• Press Releases

  Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

  June 2, 2025

   · 

  10 min read
• Press Releases

  Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis

  June 2, 2025

   · 

  5 min read
• Press Releases

  Interim Results from Ongoing Phase 2 COURAGE Trial Confirm Potential to Improve the Quality of Semaglutide (GLP-1 receptor agonist)-induced Weight Loss by Preserving Lean Mass

  June 2, 2025

   · 

  13 min read
• Press Releases

  ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis

  June 2, 2025

   · 

  2 min read
• Press Releases

  Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics

  June 2, 2025

   · 

  4 min read
• Press Releases

  Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

  June 2, 2025

   · 

  2 min read
• Press Releases

  Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)

  June 2, 2025

   · 

  8 min read
• Press Releases

  BiVACOR’s Total Artificial Heart Receives FDA Breakthrough Device Designation

  June 2, 2025

   · 

  3 min read
• Press Releases

  ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

  June 2, 2025

   · 

  5 min read